During the past decade, Klinikum Region Hannover GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Region Hannover GmbH" #1 collaborator was "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Region Hannover GmbH" are "Acute Myeloid Leukemia" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Chronic Kidney Disease" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Klinikum Region Hannover GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Region Hannover GmbH" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (2 trials), "Daunorubicin" (2 trials), "5FU/LV, Oxaliplatin, Bevacizumab, Irinotecan" (1 trials), "BI 685509" (1 trials) and "Dasatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Region Hannover GmbH" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Region Hannover GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinikum Region Hannover GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Region Hannover GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".